Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy.

Traditional testosterone replacement therapy leads to male infertility through negative feedback on the hypothalamic-pituitary-gonadal (HPG) axis.

• Exogenous testosterone suppresses the HPG axis by inhibiting gonadotropin-releasing hormone (GnRH) from the hypothalamus and luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary.
• Suppression of LH and FSH leads to reduced intratesticular testosterone production and impaired spermatogenesis.
• This suppressive effect is considered a primary concern for hypogonadal patients who wish to preserve fertility.
• The negative feedback mechanism affects both testosterone production and sperm production within the testes.

Different methods of testosterone administration have varying degrees of suppressive effects on the HPG axis.

• Recent advances in research have led to the discovery of many new methods of administration with more or less suppressive effects on the HPG axis.
• The route and formulation of testosterone delivery can influence the degree of HPG axis suppression.
• Healthcare providers must consider the impact of administration method on fertility when selecting treatment for hypogonadal patients.
• Novel delivery methods represent a potential strategy for minimizing fertility impairment during testosterone treatment.

Ancillary medications used instead of or after testosterone administration may help maintain fertility in hypogonadal patients.

• Ancillary medications can be used as alternatives to testosterone replacement therapy or as adjuncts following testosterone administration.
• These medications aim to preserve or restore spermatogenesis by maintaining HPG axis function.
• Examples of ancillary approaches include human chorionic gonadotropin (hCG), selective estrogen receptor modulators (SERMs), and aromatase inhibitors.
• The use of ancillary medications represents a key strategy for managing fertility in hypogonadal men seeking treatment.

Testosterone plays a crucial role in regulating multiple body functions in men beyond reproductive health.

• Testosterone regulates metabolic, sexual, and cardiovascular functions, as well as bone and muscle mass and mental health.
• Optimizing testosterone levels is described as 'an important step to maintaining a healthy body and mind, especially as we age.'
• The broad systemic effects of testosterone make treatment of hypogonadism clinically necessary despite risks to fertility.
• The competing needs of testosterone optimization and fertility preservation create a clinical management challenge.

This narrative review aims to provide healthcare providers with information to make appropriate treatment choices for fertility management in hypogonadal patients undergoing treatment.

• The review summarizes 'the newest methods for optimizing fertility parameters in patients undergoing treatment for hypogonadism.'
• The goal is to provide 'the necessary information for healthcare providers to make the right treatment choices.'
• The paper is structured as a narrative review of current literature on the topic.
• The review covers both testosterone administration methods and ancillary medication strategies.